Overview

Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
0
Participant gender:
All
Summary
This is a descriptive retrospective study designed to measure the efficacy of remifentanil sedation and the ability to perform frequent neurological examinations of patients with traumatic brain injuries.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Joseph D. Tobias
Treatments:
Remifentanil
Criteria
Inclusion Criteria:

- Patients previously admitted to the hospital presenting with traumatic brain injury
(TBI)

- Patients who have undergone sedation after presenting with TBI

Exclusion Criteria:

- None